Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25857346 | 0.78 | RXFP1 (0.31) | — | |
| SCHEMBL22545909 | 0.64 | KDM4E (0.36) | KDM4EMAPT | |
| SCHEMBL16691060 | 0.61 | MAPT (0.41) | KDM4EMAPT | |
| SCHEMBL9536202 | 0.59 | MEN1 (0.31) | — | |
| SCHEMBL2873824 | 0.56 | — | — | |
| SCHEMBL3209012 | 0.55 | — | — | |
| SCHEMBL13210047 | 0.54 | HASPIN (0.37) | — | |
| SCHEMBL4956793 | 0.52 | HSP90AB1 (0.48) | — | |
| SCHEMBL9604093 | 0.51 | POLB (0.37) | KDM4E | |
| SCHEMBL9210531 | 0.51 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11370797-B2 | Anti-viral drug | DORING INTERNATIONAL GMBH (CH) | 2022-06-28 | — | — | US | disclosed |
| US-20200325143-A1 | ANTI-VIRAL DRUG | DORING INTERNATIONAL GMBH (CH) | 2020-10-15 | — | — | US | disclosed |
| EP-3064501-B1 | 2-METHYLSULPHANYL-6-NITRO-7-OXO-1, 2, 4-TRIAZOLO [5, 1-C][1, 2, 4]TRIAZINIDE L-ARGININE DIHYDRATE ACTIVE TOWARD WEST NILE VIRUS | LIMITED LIABILITY COMPANY URAL CENTER OF BIOPHARMACEUTICAL TECH (RU) | 2019-08-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11370797-B2 | Anti-viral drug | NSUN3, EIF2AK2, NSUN2 | KDM4E 1788/4885MAPT 1817/4885 |
| US-20200325143-A1 | ANTI-VIRAL DRUG | NSUN3, EIF2AK2, NSUN2 | KDM4E 1788/4885MAPT 1817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.